Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing medroxyprogesterone acetate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
|
Medroxyprogest ac [endocrine] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
|
Medroxyprogesterone acetate 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
|
Medroxyprogesterone acetate 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
|
Medroxyprogesterone acetate 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
|
Medroxyprogest acetate [progestogen oral contraceptive] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
|
acétate de médroxyprogestérone 150 mg/mL, seringue préremplie de 1 mL de suspension injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
|
Medroxyprogest ac [malignancy] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
|
Medroxyprogesterone acetate 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
|
Medroxyprogesterone acetate 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
|
Medroxyprogesterone acetate 200mg/mL injection suspension 2.5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
|
Medroxyprogesterone acetate 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
|
Medroxyprogesterone acetate 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
|
Medroxyprogesterone acetate 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
|
Medroxyprogesterone acetate 400mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
|
Medroxyprogesterone acetate 150mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
|
Medroxyprogesterone acetate 10mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
|
Estradiol cypionate + medroxyprogesterone acetate 5mg/25mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
|
Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
|
Medroxyprogesterone acetate 400mg/mL injection suspension 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
|
Medroxyprogesterone acetate 150mg/mL injection suspension 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
|
Medroxyprogesterone acetate 400mg/mL injection suspension 2.5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
|
Medroxyprogesterone acetate 400mg/mL injection suspension 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
|
Product containing estradiol cypionate and medroxyprogesterone acetate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
|
Medroxyprogesterone acetate 104mg injection suspension 0.65mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
|
médicament contenant estradiol et acétate de médroxyprogestérone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
|
Injection of medroxyprogesterone acetate (procedure) |
Direct substance |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Product containing estradiol cypionate and medroxyprogesterone acetate in parenteral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
|
Product containing medroxyprogesterone acetate in parenteral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
|
Product containing medroxyprogesterone acetate in oral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
|
Medroxyprogesterone acetate 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Medroxyprogesterone acetate 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Medroxyprogesterone acetate 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Medroxyprogesterone acetate 2.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Medroxyprogesterone acetate 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Medroxyprogesterone acetate 5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Medroxyprogesterone acetate 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Medroxyprogesterone acetate 250 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Medroxyprogesterone acetate 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Medroxyprogesterone acetate 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Medroxyprogesterone acetate 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Medroxyprogesterone acetate 100 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Medroxyprogesterone acetate 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Medroxyprogesterone acetate 200 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Medroxyprogesterone acetate 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Medroxyprogesterone acetate 400 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Medroxyprogesterone acetate 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Medroxyprogesterone acetate 2.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Medroxyprogesterone acetate 100 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Medroxyprogesterone acetate 200 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Medroxyprogesterone acetate 400 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Medroxyprogesterone acetate 5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Medroxyprogesterone acetate 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Medroxyprogesterone acetate 250 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely medroxyprogesterone acetate 150 milligram/1 milliliter conventional release suspension for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely medroxyprogesterone acetate 150 milligram/1 milliliter conventional release suspension for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely medroxyprogesterone acetate 150 milligram/1 milliliter conventional release suspension for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely medroxyprogesterone acetate 150 milligram/1 milliliter conventional release suspension for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely medroxyprogesterone acetate 500 milligram/2.5 milliliter conventional release suspension for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely medroxyprogesterone acetate 500 milligram/2.5 milliliter conventional release suspension for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely medroxyprogesterone acetate 150 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely medroxyprogesterone acetate 150 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Medroxyprogesterone acetate 200 mg/mL suspension for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Medroxyprogesterone acetate 200 mg/mL suspension for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
2 |
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
2 |
Medroxyprogesterone acetate 160 mg/mL suspension for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Medroxyprogesterone acetate 160 mg/mL suspension for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
3 |
Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
3 |
Estradiol valerate 2 mg and medroxyprogesterone acetate 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Estradiol valerate 2 mg and medroxyprogesterone acetate 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
1 |
Product containing precisely conjugated estrogen 300 microgram and medroxyprogesterone acetate 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
2 |
Product containing precisely conjugated estrogen 300 microgram and medroxyprogesterone acetate 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
2 |
Product containing precisely conjugated estrogen 450 microgram and medroxyprogesterone acetate 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
2 |
Product containing precisely conjugated estrogen 450 microgram and medroxyprogesterone acetate 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
2 |
Conjugated estrogen 625 microgram and medroxyprogesterone acetate 2.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
2 |
Conjugated estrogen 625 microgram and medroxyprogesterone acetate 2.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
2 |
Estradiol cypionate 10 mg/mL and medroxyprogesterone acetate 50 mg/mL prolonged-release suspension for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
2 |
Estradiol cypionate 10 mg/mL and medroxyprogesterone acetate 50 mg/mL prolonged-release suspension for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Medroxyprogesterone acetate |
Inferred relationship |
Some |
2 |